IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
IC 009. US 021 023 026 036 038. G & S: Electronic publications in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment
IC 016. US 002 005 022 023 029 037 038 050. G & S: Publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment; questionnaires on medical issues
IC 035. US 100 101 102. G & S: Promoting awareness of patient support offerings for neurodegenerative diseases and disorders and dementia; medical referrals
IC 041. US 100 101 107. G & S: Educational services, namely, providing educational programs about neurodegenerative diseases and disorders and dementia and diagnosis, identification, management, treatment, and patient support options for these conditions; multimedia educational services in the nature of recording and production services in the fields of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management; providing on-line newsletters in the field of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management
IC 042. US 100 101. G & S: Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto
IC 044. US 100 101. G & S: Medical consulting with respect to neurodegenerative diseases and disorders and dementia, including dementia-related psychosis and their identification and treatment; providing online information for health care providers and patients in the field of neurodegenerative diseases and disorders and dementia; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients and healthcare professionals all related to neurodegenerative diseases and disorders and dementia
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|
GS0051 | Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders |